TITLE

Miyokardiyal "noncompaction": Ä°ki olgu

AUTHOR(S)
Çetin, Mecnun; Yıldırımer, Münevver; Kurdal, Adnan Taner; Coşkun, Senol
PUB. DATE
March 2011
SOURCE
Dicle Medical Journal / Dicle Tip Dergisi;2011, Vol. 38 Issue 1, p87
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Myocardial noncompaction is a rare type of congenital cardiomyopathy, characterized by trabecular network and deep trabecular recesses located in one or more ventricular segments. Patients generally present with cardiac failure, ventricular arrhythmias, and signs and symptoms related to systemic embolies. We presented two cases of myocardial noncompaction, one with left ventricular involvement and dysfunction, and the other with biventricular involvement and trabecular structures, causing right ventricular outflow tract stenosis which required surgical correction. These cases are remarkable as they had atypical clinical picture including presentation findings and treatment protocols.
ACCESSION #
59310930

 

Related Articles

  • Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients. Yifei Xu; Haiyan Lin; Ying Zhou; Gang Cheng; Geng Xu // Mediators of Inflammation;2013, Vol. 2013, p1 

    Objective. Ceruloplasmin was elevated in patients with coronary heart disease, but the relationship between ceruloplasmin and heart failure was still unknown. We aimed to evaluate ceruloplasmin in heart failure patients and assess association between ceruloplasmin and the extent of heart...

  • The New European Society of Cardiology guidelines on hypertrophic cardiomyopathy. Elliott, Perry // Heart;Apr2015, Vol. 101 Issue 7, p506 

    In this article, the author discusses the European Society of Cardiology guidelines on hypertrophic cardiomyopathy (HCM), a heart muscle disease that affects an estimated 1 in 500 adults in the general population. Topics discussed include genetic testing for the patient caused by mutations,...

  • Electrophysiological Effects of Carvedilol Administration in Patients with Dilated Cardiomyopathy. Emmanuel Kanoupakis; Emmanuel Manios; Hercules Mavrakis; Eleftherios Kallergis; George Lyrarakis; Emmanuel Koutalas; Panos Vardas // Cardiovascular Drugs & Therapy;Jun2008, Vol. 22 Issue 3, p169 

    Abstract Purpose  Several studies suggest the clinical efficacy of carvedilol in reducing atrial and ventricular arrhythmias in patients with left ventricular dysfunction (LVD) due to congestive heart failure (CHF) or following myocardial infarction. However, the mechanisms supporting its...

  • Maternal cardiovascular events during childbirth among women with congenital heart disease. Opotowsky, Alexander R.; Siddiqi, Omar K.; D'Souza, Benjamin; Webb, Gary D.; Fernandes, Susan M.; Landzberg, Michael J. // Heart;Jan2012, Vol. 98 Issue 2, p145 

    Objectives To define the epidemiology of adverse cardiovascular events among women with congenital heart disease (CHD) hospitalised for childbirth in the USA. Design and setting The 1998-2007 Nationwide Inpatient Sample, an administrative dataset representative of overall US hospital admissions,...

  • Primary Cardiac Tumors. Leja, Monika J.; Shah, Dipan J.; Reardon, Michael J. // Texas Heart Institute Journal;2011, Vol. 38 Issue 3, p261 

    The article provides information on primary cardiac tumors. Surgery and autopsy reports reveal that the incidence of such tumor is 0.3% to 0.7% of all cardiac tumors, with only 25% malignant, and of these, 75% are sarcomas. Symptoms are said to be dependent upon tumor location and size and its...

  • heart valve. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p372 

    An encyclopedia entry for "heart valve" is presented. It refers to a structure at the exit of a heart chamber, consisting of two or three cup-shaped flaps. It notes the function of a heart valve which is to allow blood to flow out of the chamber but prevents it from washing back. It also...

  • Resting perfusion MPI-SPECT combined with cardiac I- mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: Sub-study from the ADMIRE-HF trial. Sood, Nitesh; Al Badarin, Firas; Parker, Matthew; Pullatt, Raja; Jacobson, Arnold; Bateman, Timothy; Heller, Gary // Journal of Nuclear Cardiology;Oct2013, Vol. 20 Issue 5, p813 

    Background: Delayed Iodine-123 meta-iodobenzylguanidine heart/mediastinum ( H/ M) uptake ratio predicted arrhythmic events in patients with heart failure (HF) and significant left ventricular dysfunction in ADMIRE-HF. We tested the hypothesis that resting perfusion defects on MPI-SPECT,...

  • Fluorouracil.  // Reactions Weekly;6/25/2011, Issue 1357, p16 

    The article describes the case of a 14-year-old boy who developed dilated cardiomyopathy and a possible arrhythmia leading to death, during treatment with fluorouracil for metastatic nasopharyngeal carcinoma.

  • Intrinsic heterogeneity in repolarization is increased in isolated failing rabbit cardiomyocytes during simulated ischemia. de Groot, Joris R.; Schumacher, Cees A.; Verkerk, Arie O.; Baartscheer, Antonius; Fiolet, Jan W.T.; Coronel, Ruben // Cardiovascular Research;Sep2003, Vol. 59 Issue 3, p705 

    Objective: Myocardial ischemia and ventricular arrhythmias often complicate congestive heart failure. Ischemia-induced dispersion in repolarization is an important arrhythmogenic factor that might be caused by intrinsic cellular differences in response to simulated ischemia (SI) or by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics